Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2019

Feb 14, 2019

30237_dirs_2019-02-14_8ebe6207-e935-4fa5-9b20-d25fbe96c3b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2019-02-12

Reporting Person: BERBERIAN LANCE (SVP, Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-12 Common Stock M 233 Acquired 8826 Direct
2019-02-12 Common Stock F 70 $146.59 Disposed 8756 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-12 Restricted Stock Unit $ M 233 Disposed Common Stock (233) Direct
2019-02-12 Restricted Stock Unit $ A 1060 Acquired Common Stock (1060) Direct
2019-02-12 Restricted Stock Unit $ A 7060 Acquired Common Stock (7060) Direct
2019-02-12 Non-qualified Stock Options $146.59 A 4400 Acquired 2029-02-11 Common Stock (4400) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020.

F6: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F7: The option vests in three equal installments beginning on the date reflected in this column.